Atropine Sulfate Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Jan 1, 2012. Reported reason: Other

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-580-20
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)
Initial Posting
Jan 1, 2012

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.